These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 20206973

  • 1. Can saturation biopsy predict prostate cancer localization in radical prostatectomy specimens: a correlative study and implications for focal therapy.
    Falzarano SM, Zhou M, Hernandez AV, Moussa AS, Jones JS, Magi-Galluzzi C.
    Urology; 2010 Sep; 76(3):682-7. PubMed ID: 20206973
    [Abstract] [Full Text] [Related]

  • 2. Discrepancy in prostate cancer localization between biopsy and prostatectomy specimens in patients with unilateral positive biopsy: implications for focal therapy.
    Sinnott M, Falzarano SM, Hernandez AV, Jones JS, Klein EA, Zhou M, Magi-Galluzzi C.
    Prostate; 2012 Aug 01; 72(11):1179-86. PubMed ID: 22161896
    [Abstract] [Full Text] [Related]

  • 3. The role of transrectal saturation biopsy in tumour localization: pathological correlation after retropubic radical prostatectomy and implication for focal ablative therapy.
    Abdollah F, Scattoni V, Raber M, Roscigno M, Briganti A, Suardi N, Gallina A, Capitanio U, Freschi M, Salonia A, Cestari A, Guazzoni G, Rigatti P, Montorsi F.
    BJU Int; 2011 Aug 01; 108(3):366-71. PubMed ID: 21087451
    [Abstract] [Full Text] [Related]

  • 4. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy.
    Sebo TJ, Bock BJ, Cheville JC, Lohse C, Wollan P, Zincke H.
    J Urol; 2000 Jan 01; 163(1):174-8. PubMed ID: 10604340
    [Abstract] [Full Text] [Related]

  • 5. The percentage of prostate needle biopsy cores with carcinoma from the more involved side of the biopsy as a predictor of prostate specific antigen recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
    Freedland SJ, Aronson WJ, Terris MK, Kane CJ, Amling CL, Dorey F, Presti JC.
    Cancer; 2003 Dec 01; 98(11):2344-50. PubMed ID: 14635068
    [Abstract] [Full Text] [Related]

  • 6. Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients.
    King CR, McNeal JE, Gill H, Presti JC.
    Int J Radiat Oncol Biol Phys; 2004 Jun 01; 59(2):386-91. PubMed ID: 15145152
    [Abstract] [Full Text] [Related]

  • 7. Unilateral prostate cancer cannot be accurately predicted in low-risk patients.
    Isbarn H, Karakiewicz PI, Vogel S, Jeldres C, Lughezzani G, Briganti A, Montorsi F, Perrotte P, Ahyai SA, Budäus L, Eichelberg C, Heuer R, Köllermann J, Sauter G, Schlomm T, Steuber T, Haese A, Zacharias M, Fisch M, Heinzer H, Huland H, Chun FK, Graefen M.
    Int J Radiat Oncol Biol Phys; 2010 Jul 01; 77(3):784-7. PubMed ID: 19864083
    [Abstract] [Full Text] [Related]

  • 8. Utility of saturation biopsy to predict insignificant cancer at radical prostatectomy.
    Epstein JI, Sanderson H, Carter HB, Scharfstein DO.
    Urology; 2005 Aug 01; 66(2):356-60. PubMed ID: 16040085
    [Abstract] [Full Text] [Related]

  • 9. Can contemporary transrectal prostate biopsy accurately select candidates for hemi-ablative focal therapy of prostate cancer?
    Tareen B, Godoy G, Sankin A, Temkin S, Lepor H, Taneja SS.
    BJU Int; 2009 Jul 01; 104(2):195-9. PubMed ID: 19191784
    [Abstract] [Full Text] [Related]

  • 10. Comparison of digital rectal examination and biopsy results with the radical prostatectomy specimen.
    Obek C, Louis P, Civantos F, Soloway MS.
    J Urol; 1999 Feb 01; 161(2):494-8; discussion 498-9. PubMed ID: 9915434
    [Abstract] [Full Text] [Related]

  • 11. Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer.
    Noguchi M, Stamey TA, McNeal JE, Yemoto CM.
    J Urol; 2001 Jul 01; 166(1):104-9; discussion 109-10. PubMed ID: 11435833
    [Abstract] [Full Text] [Related]

  • 12. Increasing the number of biopsies increases the concordance of Gleason scores of needle biopsies and prostatectomy specimens.
    Divrik RT, Eroglu A, Sahin A, Zorlu F, Ozen H.
    Urol Oncol; 2007 Jul 01; 25(5):376-82. PubMed ID: 17826653
    [Abstract] [Full Text] [Related]

  • 13. Prostate needle biopsies: multiple variables are predictive of final tumor volume in radical prostatectomy specimens.
    Poulos CK, Daggy JK, Cheng L.
    Cancer; 2004 Aug 01; 101(3):527-32. PubMed ID: 15274065
    [Abstract] [Full Text] [Related]

  • 14. Is quantitative histologic examination useful to predict nonorgan-confined prostate cancer when saturation biopsy is performed?
    Pepe P, Fraggetta F, Galia A, Grasso G, Piccolo S, Aragona F.
    Urology; 2008 Dec 01; 72(6):1198-202. PubMed ID: 19041023
    [Abstract] [Full Text] [Related]

  • 15. Percentages of positive cores, cancer length and Gleason grade 4/5 cancer in systematic sextant biopsy are all predictive of adverse pathology and biochemical failure after radical prostatectomy.
    Suekane S, Noguchi M, Nakashima O, Yamada S, Kojiro M, Matsuoka K.
    Int J Urol; 2007 Aug 01; 14(8):713-8. PubMed ID: 17681061
    [Abstract] [Full Text] [Related]

  • 16. Percentage of positive biopsy cores, preoperative prostate-specific antigen (PSA) level, pT and Gleason score as predictors of PSA recurrence after radical prostatectomy: a multi-institutional outcome study in Japan.
    Yokomizo A, Murai M, Baba S, Ogawa O, Tsukamoto T, Niwakawa M, Tobisu K, Kinukawa N, Naito S.
    BJU Int; 2006 Sep 01; 98(3):549-53. PubMed ID: 16925752
    [Abstract] [Full Text] [Related]

  • 17. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies.
    Stewart CS, Leibovich BC, Weaver AL, Lieber MM.
    J Urol; 2001 Jul 01; 166(1):86-91; discussion 91-2. PubMed ID: 11435830
    [Abstract] [Full Text] [Related]

  • 18. Predicting unilateral prostate cancer based on biopsy features: implications for focal ablative therapy--results from the SEARCH database.
    Scales CD, Presti JC, Kane CJ, Terris MK, Aronson WJ, Amling CL, Freedland SJ, SEARCH Database Study Group.
    J Urol; 2007 Oct 01; 178(4 Pt 1):1249-52. PubMed ID: 17698131
    [Abstract] [Full Text] [Related]

  • 19. Patient selection for hemiablative focal therapy of prostate cancer: variables predictive of tumor unilaterality based upon radical prostatectomy.
    Polascik TJ, Mayes JM, Schroeck FR, Sun L, Madden JF, Moul JW, Mouraviev V.
    Cancer; 2009 May 15; 115(10):2104-10. PubMed ID: 19288576
    [Abstract] [Full Text] [Related]

  • 20. Micro-focal prostate cancer: a comparison of biopsy and radical prostatectomy specimen features.
    Boccon-Gibod LM, Dumonceau O, Toublanc M, Ravery V, Boccon-Gibod LA.
    Eur Urol; 2005 Dec 15; 48(6):895-9. PubMed ID: 16125298
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.